• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板内皮细胞黏附分子-1(CD31)对抗抗原受体信号的抑制作用需要功能性免疫受体酪氨酸抑制基序(ITIMs)、含Src同源2结构域蛋白酪氨酸磷酸酶-2(SHP-2)和p56(lck)。

Inhibition of antigen-receptor signaling by Platelet Endothelial Cell Adhesion Molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56(lck).

作者信息

Newman D K, Hamilton C, Newman P J

机构信息

Blood Research Institute, The Blood Center of Southeastern Wisconsin, Milwaukee, WI 53233, USA.

出版信息

Blood. 2001 Apr 15;97(8):2351-7. doi: 10.1182/blood.v97.8.2351.

DOI:10.1182/blood.v97.8.2351
PMID:11290597
Abstract

Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1, CD31) is a 130-kd member of the immunoglobulin gene superfamily that is expressed on the surface of platelets, endothelial cells, myeloid cells, and certain lymphocyte subsets. PECAM-1 has recently been shown to contain functional immunoreceptor tyrosine-based inhibitory motifs (ITIMs) within its cytoplasmic domain, and co-ligation of PECAM-1 with the T-cell antigen receptor (TCR) results in tyrosine phosphorylation of PECAM-1, recruitment of Src homology 2 domain-containing protein tyrosine phosphatase-2 (SHP-2), and attenuation of TCR-mediated cellular signaling. To determine the molecular basis of PECAM-1 inhibitory signaling in lymphocytes, the study sought to (1) establish the importance of the PECAM-1 ITIMs for its inhibitory activity, (2) determine the relative importance of SHP-2 versus SHP-1 in mediating the inhibitory effect of PECAM-1, and (3) identify the protein tyrosine kinases required for PECAM-1 tyrosine phosphorylation in T cells. Co-ligation of wild-type PECAM-1 with the B-cell antigen receptor expressed on chicken DT40 B cells resulted in a marked reduction of calcium mobilization-similar to previous observations in T cells. In contrast, co-ligation of an ITIM-less form of PECAM-1 had no inhibitory effect. Furthermore, wild-type PECAM-1 was unable to attenuate calcium mobilization in SHP-2-deficient DT40 variants despite abundant levels of SHP-1 in these cells. Finally, PECAM-1 failed to become tyrosine phosphorylated in p56(lck)-deficient Jurkat T cells. Together, these data provide important insights into the molecular requirements for PECAM-1 regulation of antigen receptor signaling.

摘要

血小板内皮细胞黏附分子-1(PECAM-1,CD31)是免疫球蛋白基因超家族的一个130千道尔顿成员,表达于血小板、内皮细胞、髓样细胞及某些淋巴细胞亚群的表面。最近研究表明,PECAM-1在其胞质结构域中含有功能性基于免疫受体酪氨酸的抑制基序(ITIMs),PECAM-1与T细胞抗原受体(TCR)的共连接导致PECAM-1的酪氨酸磷酸化、含Src同源2结构域的蛋白酪氨酸磷酸酶-2(SHP-2)的募集以及TCR介导的细胞信号转导的减弱。为确定淋巴细胞中PECAM-1抑制性信号传导的分子基础,该研究试图:(1)确定PECAM-1的ITIMs对其抑制活性的重要性;(2)确定SHP-2与SHP-1在介导PECAM-1抑制作用中的相对重要性;(3)鉴定T细胞中PECAM-1酪氨酸磷酸化所需的蛋白酪氨酸激酶。野生型PECAM-1与鸡DT40 B细胞上表达的B细胞抗原受体的共连接导致钙动员显著减少——这与先前在T细胞中的观察结果相似。相比之下,缺乏ITIM的PECAM-1形式的共连接没有抑制作用。此外,尽管这些细胞中SHP-1水平丰富,但野生型PECAM-1无法减弱SHP-2缺陷型DT40变体中的钙动员。最后,PECAM-1在p56(lck)缺陷的Jurkat T细胞中未能发生酪氨酸磷酸化。总之,这些数据为PECAM-1调节抗原受体信号传导的分子要求提供了重要见解。

相似文献

1
Inhibition of antigen-receptor signaling by Platelet Endothelial Cell Adhesion Molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56(lck).血小板内皮细胞黏附分子-1(CD31)对抗抗原受体信号的抑制作用需要功能性免疫受体酪氨酸抑制基序(ITIMs)、含Src同源2结构域蛋白酪氨酸磷酸酶-2(SHP-2)和p56(lck)。
Blood. 2001 Apr 15;97(8):2351-7. doi: 10.1182/blood.v97.8.2351.
2
Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling.含Src同源2结构域的蛋白酪氨酸磷酸酶SHP-1和SHP-2是血小板内皮细胞黏附分子1/CD31介导的抑制性信号传导所必需的。
J Immunol. 2001 Mar 1;166(5):3098-106. doi: 10.4049/jimmunol.166.5.3098.
3
Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of platelet/endothelial cell adhesion molecule-1 (PECAM-1) that are required for the cellular association and activation of the protein-tyrosine phosphatase, SHP-2.血小板/内皮细胞黏附分子-1(PECAM-1)胞质结构域中磷酸酪氨酸结合基序的表征,这些基序是蛋白酪氨酸磷酸酶SHP-2细胞结合和激活所必需的。
J Biol Chem. 1997 Oct 3;272(40):24868-75. doi: 10.1074/jbc.272.40.24868.
4
Targeting Src homology 2 domain-containing tyrosine phosphatase (SHP-1) into lipid rafts inhibits CD3-induced T cell activation.将含Src同源2结构域的酪氨酸磷酸酶(SHP-1)靶向定位于脂筏可抑制CD3诱导的T细胞活化。
J Immunol. 2001 Mar 15;166(6):3975-82. doi: 10.4049/jimmunol.166.6.3975.
5
SHP-1 regulates Lck-induced phosphatidylinositol 3-kinase phosphorylation and activity.SHP-1调节Lck诱导的磷脂酰肌醇3-激酶磷酸化及活性。
J Biol Chem. 1999 Sep 24;274(39):27583-9. doi: 10.1074/jbc.274.39.27583.
6
Recruitment and activation of SHP-1 protein-tyrosine phosphatase by human platelet endothelial cell adhesion molecule-1 (PECAM-1). Identification of immunoreceptor tyrosine-based inhibitory motif-like binding motifs and substrates.人血小板内皮细胞黏附分子-1(PECAM-1)对SHP-1蛋白酪氨酸磷酸酶的募集与激活。基于免疫受体酪氨酸的抑制基序样结合基序及底物的鉴定。
J Biol Chem. 1998 Oct 23;273(43):28332-40. doi: 10.1074/jbc.273.43.28332.
7
CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1.CD5负向调节T细胞抗原受体信号转导通路:含SH2结构域的磷酸酪氨酸磷酸酶SHP-1的参与。
Mol Cell Biol. 1999 Apr;19(4):2903-12. doi: 10.1128/MCB.19.4.2903.
8
A new role for platelet-endothelial cell adhesion molecule-1 (CD31): inhibition of TCR-mediated signal transduction.血小板内皮细胞黏附分子-1(CD31)的新作用:抑制T细胞受体介导的信号转导。
J Immunol. 1999 Jul 15;163(2):682-8.
9
The protein-tyrosine phosphatase SHP-2 associates with tyrosine-phosphorylated adhesion molecule PECAM-1 (CD31).蛋白酪氨酸磷酸酶SHP-2与酪氨酸磷酸化的黏附分子PECAM-1(CD31)相关联。
J Biol Chem. 1997 Dec 5;272(49):31086-91. doi: 10.1074/jbc.272.49.31086.
10
Differential association of cytoplasmic signalling molecules SHP-1, SHP-2, SHIP and phospholipase C-gamma1 with PECAM-1/CD31.细胞质信号分子SHP-1、SHP-2、SHIP和磷脂酶C-γ1与PECAM-1/CD31的差异关联
FEBS Lett. 1999 Apr 30;450(1-2):77-83. doi: 10.1016/s0014-5793(99)00446-9.

引用本文的文献

1
CD31 regulates metabolic switch in Treg migration attenuates rheumatoid arthritis.CD31调节调节性T细胞迁移中的代谢转换,减轻类风湿性关节炎。
Clin Transl Med. 2025 Aug;15(8):e70441. doi: 10.1002/ctm2.70441.
2
Single-cell sequencing reveals the immune landscape of breast cancer patients with brain metastasis.单细胞测序揭示伴脑转移乳腺癌患者的免疫景观。
Thorac Cancer. 2024 Mar;15(9):702-714. doi: 10.1111/1759-7714.15243. Epub 2024 Feb 5.
3
Interactions between Platelets and Tumor Microenvironment Components in Ovarian Cancer and Their Implications for Treatment and Clinical Outcomes.
卵巢癌中血小板与肿瘤微环境成分之间的相互作用及其对治疗和临床结果的影响。
Cancers (Basel). 2023 Feb 17;15(4):1282. doi: 10.3390/cancers15041282.
4
Modulation of TCR Signaling by Tyrosine Phosphatases: From Autoimmunity to Immunotherapy.酪氨酸磷酸酶对TCR信号的调节:从自身免疫到免疫治疗
Front Cell Dev Biol. 2020 Dec 9;8:608747. doi: 10.3389/fcell.2020.608747. eCollection 2020.
5
CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma.CD155 的免疫调节作用可作为胶质母细胞瘤中自然杀伤细胞免疫治疗的靶点。
J Hematol Oncol. 2020 Jun 12;13(1):76. doi: 10.1186/s13045-020-00913-2.
6
CD31 Acts as a Checkpoint Molecule and Is Modulated by FcγR-Mediated Signaling in Monocytes.CD31 作为一个检查点分子,通过 FcγR 介导的信号在单核细胞中被调节。
J Immunol. 2019 Dec 15;203(12):3216-3224. doi: 10.4049/jimmunol.1900059. Epub 2019 Nov 15.
7
Biophysical basis underlying dynamic Lck activation visualized by ZapLck FRET biosensor.ZapLck FRET 生物传感器直观呈现动态 Lck 激活的生物物理基础。
Sci Adv. 2019 Jun 19;5(6):eaau2001. doi: 10.1126/sciadv.aau2001. eCollection 2019 Jun.
8
PECAM-1 Stabilizes Blood-Brain Barrier Integrity and Favors Paracellular T-Cell Diapedesis Across the Blood-Brain Barrier During Neuroinflammation.PECAM-1 稳定血脑屏障完整性,并有利于神经炎症期间血脑屏障的细胞旁 T 细胞穿越。
Front Immunol. 2019 Apr 5;10:711. doi: 10.3389/fimmu.2019.00711. eCollection 2019.
9
1,25-Dihydroxyvitamin D Restrains CD4 T Cell Priming Ability of CD11c Dendritic Cells by Upregulating Expression of CD31.1,25-二羟维生素 D 通过上调 CD31 的表达来抑制 CD11c 树突状细胞的 CD4 T 细胞启动能力。
Front Immunol. 2019 Mar 28;10:600. doi: 10.3389/fimmu.2019.00600. eCollection 2019.
10
CD300A promotes tumor progression by PECAM1, ADCY7 and AKT pathway in acute myeloid leukemia.在急性髓系白血病中,CD300A通过PECAM1、ADCY7和AKT途径促进肿瘤进展。
Oncotarget. 2018 Jan 11;9(44):27574-27584. doi: 10.18632/oncotarget.24164. eCollection 2018 Jun 8.